Literature DB >> 12429265

Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis.

Sunila Jain1, Frank Proudlock, Cris S Constantinescu, Irene Gottlob.   

Abstract

PURPOSE: To describe a combined pharmacological and surgical approach to treating acquired nystagmus in a patient with multiple sclerosis.
DESIGN: Interventional case report.
METHODS: A 40-year-old patient with acquired horizontal and vertical nystagmus and severe oscillopsia secondary to multiple sclerosis had combined treatment with gabapentin and a vertical Kestenbaum-type procedure.
RESULTS: After gabapentin treatment (3,000 mg orally daily) the horizontal nystagmus was significantly reduced, and the patient developed a marked chin-up position. The vertical nystagmus remained unchanged, dampening on downgaze. A recession of both inferior rectus muscles reduced the nystagmus significantly in primary position, the abnormal head position disappeared, and oscillopsia completely resolved. Treatment increased visual acuity from 6/24 in the right eye and 6/60 in the left eye to 6/9 in both eyes.
CONCLUSIONS: Acquired nystagmus in multiple sclerosis can be significantly improved by using a combined pharmacological and surgical approach.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429265     DOI: 10.1016/s0002-9394(02)01629-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?

Authors:  Rebecca Jane McLean; Irene Gottlob; Frank Antony Proudlock
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

2.  Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.

Authors:  Michaela Starck; Holger Albrecht; Walter Pöllmann; Marianne Dieterich; Andreas Straube
Journal:  J Neurol       Date:  2009-09-13       Impact factor: 4.849

3.  The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.

Authors:  T Shery; F A Proudlock; N Sarvananthan; R J McLean; I Gottlob
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

4.  Current Treatment of Nystagmus.

Authors:  Janet C Rucker
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972

5.  Eye disorders in patients with multiple sclerosis: natural history and management.

Authors:  Jennifer Graves; Laura J Balcer
Journal:  Clin Ophthalmol       Date:  2010-12-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.